A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia

Alia Bahtar (Selangor, Malaysia), Alia Bahtar, Roslina Abdul Manap, Andrea Ban

Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Session: Community-acquired pneumonia: risk classes and management issues
Session type: Thematic Poster
Number: 2591
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alia Bahtar (Selangor, Malaysia), Alia Bahtar, Roslina Abdul Manap, Andrea Ban. A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia. Eur Respir J 2016; 48: Suppl. 60, 2591

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-acquired pneumonia due to streptococcus pneumoniae in hospitalized patients – mortality predictors
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Penicillin-resistant streptococcus pneumoniae is a rare etiology of community-acquired pneumonia requiring hospitalization: results from the CAPO international cohort study
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009


Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010



Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Antimicrobial-resistance in streptococcus pneumoniae isolates causing pneumonia in Spanish people over 50 years
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Bacteraemia in outpatients with community-acquired pneumonia
Source: Eur Respir J 2016; 47: 654-657
Year: 2016


Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 608s
Year: 2002

Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2001; 18: Suppl. 33, 140s
Year: 2001

Severe Chlamydia pneumoniae community-acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 545s
Year: 2003

Influence of streptococcus pneumoniae serotypes in clinical outcomes of pneumonias
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011


Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Source: Eur Respir J 2003; 21: 741-742
Year: 2003


Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002



Penicillin-resistance in Streptococcus pneumoniae isolates among adults with community-acquired pneumonia in the region of Tarragona, Spain
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008


Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013